Horizon Scanning

It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.

The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:

  • Is this emerging technology new or replacing an existing technology?
  • Where is this technology in the FDA regulatory process?
  • When will this technology be commercially available in the market?
  • What is the projected use, cost, and financial impact of this technology?

Zio Patch

A single-use, ambulatory, electrocardiographic monitor configured as an adhesive patch and capable of collecting data continuously for up to 14 days, intended as an alternative to Holter monitoring for patients with symptoms of arrhythmia.

Tafinlar (Dabrafenib)

Also being developed for second-line treatment of metastatic BRAF V600E mutation-positive non-small cell lung cancer.

Mekinist (Trametinib)

An oral drug for the treatment of advanced melanoma in patients with BRAF V600E and V600K mutations.

NovoTTF-100A System

A noninvasive portable device that delivers alternating electrical fields to the brain via electrodes applied to the scalp to treat adult patients with glioblastoma multiforme after standard therapies fail.  

Mobi-C Artificial Cervical Disc

An artificial cervical disc for the treatment of single-level and 2-level total disc replacement in patients with symptomatic cervical degenerative disc disease unresponsive to conservative treatments.

MitraClip Delivery System

A catheter-delivered implantable device used to perform percutaneous mitral valve repair in patients with moderately severe to severe mitral regurgitation.